Diagnostic and Biotech

Global Cancer Vaccines Market 2015-2019

  • TEC250642
  • 64 Pages
  • June 2015
  • Diagnostic and Biotech
About Cancer Vaccines

Cancer vaccines are biological preparations that stimulate or strengthen a persons immune system against cancer. Cancer vaccines are usually administered
intravenously. They can be used in both adults and children. The vaccines can be broadly classified into two: prophylactic and therapeutic vaccines. Prophylactic
vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer.

Technavio's analysts forecast the global cancer vaccines market to grow at a CAGR of 27.24% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019. To calculate the market size, the
report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines.

This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019 in the following three regions:

Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
EMEA: The principal countries focused upon in this region are the UK; Germany; Italy; France; Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE
APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India. APAC is one of the major markets that is

untapped by the leading vendors

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers that
influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the
market.

Technavio's report, Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report
covers the Americas, EMEA, and APAC; it also covers the global cancer vaccines market landscape and its growth prospects in the coming years. The report also includes
a discussion of the key vendors operating in this market.

Key Regions
Americas
APAC
EMEA

Key Vendors
Dendreon
GlaxoSmithKline
Merck

Other Prominent Vendors
Aduro BioTech
Advantagene
Advaxis
Agenus
AlphaVax
Altor BioScience
Amgen
Antigen Express
Argos Therapeutics
AVAX Technologies
Bavarian Nordic
Biothera
Bristol-Myers Squibb
Celldex Therapeutics
Cel-Sci
CureVac
Cytos
Galena Biopharma
Genexine
GlobeImmune
Gradalis
Heat Biologics
Immatics
ImmunoCellular Therapeutics
Immutep
Inovio Pharmaceuticals
Isa Pharmaceuticals
Juvaris Biotherapeutics
MedImmune
NewLink Genetics
Northwest Biotherapeutics
NovaRx
OncoThyreon
Oncovir
Oxford BioMedica
Prima BioMed
Progenics
Provectus Biopharmaceuticals
Sanofi
Sotio
Transgene
Ubivac
Vaccinogen
Vaxon Biotech
Vical

Market Driver
Increased Prevalence of Cancers
For a full, detailed list, view our report

Market Challenge
Cold Chain Management
For a full, detailed list, view our report

Market Trend
Strategic Alliances
For a full, detailed list, view our report

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>